Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial

STUDY OBJECTIVES: Post hoc analyses from the phase 3 REST-ON trial evaluated efficacy of extended-release once-nightly sodium oxybate (ON-SXB; FT218) vs placebo for daytime sleepiness and disrupted nighttime sleep in narcolepsy type 1 (NT1) and 2 (NT2). METHODS: Participants were stratified by narco...

Descripción completa

Detalles Bibliográficos
Autores principales: Dauvilliers, Yves, Roth, Thomas, Bogan, Richard, Thorpy, Michael J, Morse, Anne Marie, Roy, Asim, Dubow, Jordan, Gudeman, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neurological Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636255/
https://www.ncbi.nlm.nih.gov/pubmed/37246913
http://dx.doi.org/10.1093/sleep/zsad152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636255/
https://www.ncbi.nlm.nih.gov/pubmed/37246913
http://dx.doi.org/10.1093/sleep/zsad152

Ejemplares similares